Australian biotech company launches early detection technology for shrimp diseases
A single test can accurately detect 18 shrimp diseases and identify genetic variations
Genics, an Australian biotech firm, launched Shrimp MultiPath2.0 – an advanced technology for the early detection of shrimp diseases.
The technology differs from traditional kits and services by enabling the identification of 18 shrimp pathogens in a single test, as opposed to just one pathogen per sample. Shrimp MultiPath2.0 not only provides highly accurate detection of various diseases but also distinguishes between genetic subvariants of major pathogens, ensuring comprehensive protection for farmers.
“Genics Shrimp MultiPath2.0 acts as an early warning system, alerting farmers to the presence of pathogens weeks before any visible signs of illness appear in their animals,” Genics stated in a release. “This proactive approach is invaluable in preventing costly stock losses and maintaining the health of the aquaculture environment.”
“In the case of infectious hypodermal and hematopoietic necrosis virus (IHHNV), Shrimp MultiPath2.0 can significantly increase farm gate value by up to US $52,000.00 per hectare. For devastating pathogens like white spot syndrome virus (WSSV) and IMNV, Shrimp MultiPath2.0 has the potential to save entire harvests, sparing farmers from substantial financial setbacks.”
Minutes, not days: Partnership takes aim at rapid tests for shrimp diseases
The technology detects a broad spectrum of pathogens, focusing on the most economically damaging. This comprehensive, targeted approach enables farmers to defend against the most critical disease threats efficiently.
Moreover, Shrimp MultiPath2.0 includes control tests that validate the integrity of DNA and RNA in every sample, setting the bar higher than industry standards. This precision is particularly crucial for shrimp, which contain PCR inhibitors like chitin.
“Shrimp MultiPath2.0 is a genuine innovation in shrimp pathogen detection, addressing the industry’s need for a comprehensive, fast and accurate testing solution,” wrote Genics. “With its ability to detect a wide range of pathogens, deliver swift results and provide secure, verified quantitative data, Shrimp MultiPath2.0 sets a new standard for certainty and safety.”
Now that you've reached the end of the article ...
… please consider supporting GSA’s mission to advance responsible seafood practices through education, advocacy and third-party assurances. The Advocate aims to document the evolution of responsible seafood practices and share the expansive knowledge of our vast network of contributors.
By becoming a Global Seafood Alliance member, you’re ensuring that all of the pre-competitive work we do through member benefits, resources and events can continue. Individual membership costs just $50 a year.
Not a GSA member? Join us.
Author
Related Posts
Health & Welfare
Australian biotech company snags award for ‘ground-breaking’ shrimp pathogen detection product
Genics' shrimp pathogen detection product can detect 14 pathogens in one test, saving money and leading to early disease detection
Health & Welfare
Genics Shrimp Multipath Technology exceeds global standards for WSSV detection
Early detection of major shrimp pathogens – through novel technologies like Genics Shrimp Multipath – is key for WSSV control and prevention.
Health & Welfare
New Infectious Myonecrosis Virus variant linked with recent disease outbreaks in Pacific white shrimp in Brazil
Findings highlight the importance of proper screening of live shrimp to prevent the spread of potentially lethal shrimp diseases globally.
Health & Welfare
Rapid on-site diagnostic tool for AHPND management
To help minimize economic losses caused by acute hepatopancreatic necrosis disease, timely detection of its pathogenic Vibrio etiological agent plays a critical part in disease management. A portable device with accompanying polymerase chain reaction assays can quickly identify the AHPND markers in shrimp, water, live feed or other sources.